CHCT · Community Healthcare Trust Inc

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.14 to $15.27. The reporting person undertakes to provide Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) of this Form 4.

The Company awarded the reporting person 10,163 time-based restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Company's common stock, and will vest in approximately equal, 1/3 installments on each of June 30, 2027, 2028 and 2029, provided that the reporting person remains continuously employed by the Company on each such date.

The Company awarded the reporting person 15,573 time-based restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Company's common stock, and will vest in approximately equal, 1/3 installments on each of June 30, 2027, 2028 and 2029, provided that the reporting person remains continuously employed by the Company on each such date.

The Company awarded the reporting person 8,589 time-based restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Company's common stock, and will vest in approximately equal, 1/3 installments on each of June 30, 2027, 2028 and 2029, provided that the reporting person remains continuously employed by the Company on each such date.

For 2026, the reporting person elected to take 100% of her Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take her Board retainer for 2026 in shares of restricted stock in lieu of cash, the Company awarded her additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $17.23. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2026, the reporting person elected to take 50% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 50% of his Board retainer for 2026 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the deferred Board retainer. The price of the securities acquired by the reporting person with respect to the deferred Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $17.23. The number of securities issued is equal to the total value of the deferred Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2026, the reporting person elected to take 100% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take his Board retainer for 2026 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $17.23. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2026, the reporting person elected to take 76.5% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 76.5% of his Board retainer for 2026 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the deferred Board retainer. The price of the securities acquired by the reporting person with respect to the deferred Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $17.23. The number of securities issued is equal to the total value of the deferred Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2026, the reporting person elected to take 100% of her Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take her Board retainer for 2026 in shares of restricted stock in lieu of cash, the Company awarded her additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $17.23. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2026, the reporting person agreed to take 50% of her salary in shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 50% of her base salary for 2026 in shares of restricted stock with a three-year restriction period, the Company awarded Ms. Stach additional compensation, in restricted stock, equal to 15% of her annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2026, which was $16.70.

For 2026, the reporting person agreed to take 50% of his salary in shares of restricted stock with a five-year restriction period. Because the reporting person elected to take 50% of his base salary for 2026 in shares of restricted stock with a five-year restriction period, the Company awarded Mr. Dupuy additional compensation, in restricted stock, equal to 25% of his annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2026, which was $16.70.

For 2026, the reporting person agreed to take 50% of his salary in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take 50% of his base salary for 2026 in shares of restricted stock with an eight-year restriction period, the Company awarded Mr. Monroe additional compensation, in restricted stock, equal to 50% of his annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2026, which was $16.70.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.56 to $14.66. The reporting person undertakes to provide Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) of this Form 4.

For 2025, the reporting person agreed to take 50% of his cash bonus in shares of restricted stock with a five-year restriction period. Because the reporting person elected to take 50% of his bonus for 2025 in shares of restricted stock with a five-year restriction period, the Company awarded Mr. Dupuy additional compensation, in restricted stock, equal to 25% of his cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 7, 2025, which was $15.85.

For 2025, the reporting person agreed to take 50% of his cash bonus in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take 50% of his bonus for 2025 in shares of restricted stock with an eight-year restriction period, the Company awarded Mr. Monroe additional compensation, in restricted stock, equal to 50% of his cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 7, 2025, which was $15.85.

For 2025, the reporting person agreed to take 50% of her cash bonus in shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 50% of her bonus for 2025 in shares of restricted stock with a three-year restriction period, the Company awarded Ms. Stach additional compensation, in restricted stock, equal to 15% of her cash bonus. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding August 7, 2025, which was $15.85.

The Company awarded the reporting person 17,518 time-based restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Company's common stock, and will vest in approximately equal, 1/3 installments on each of June 30, 2026, 2027 and 2028, provided that the reporting person remains continuously employed by the Company on each such date.

The Company awarded the reporting person 9,662 time-based restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Company's common stock, and will vest in approximately equal, 1/3 installments on each of June 30, 2026, 2027 and 2028, provided that the reporting person remains continuously employed by the Company on each such date.

The Company awarded the reporting person 11,433 time-based restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Company's common stock, and will vest in approximately equal, 1/3 installments on each of June 30, 2026, 2027 and 2028, provided that the reporting person remains continuously employed by the Company on each such date.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.29 to $16.55. The reporting person undertakes to provide Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) of this Form 4.

For 2025, the reporting person elected to take 100% of her Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take her Board retainer for 2025 in shares of restricted stock in lieu of cash, the Company awarded her additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $16.64. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2025, the reporting person elected to take 100% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take his Board retainer for 2025 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $16.64. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2025, the reporting person elected to take 100% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take his Board retainer for 2025 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $16.64. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2025, the reporting person elected to take 76.5% of his Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 76.5% of his Board retainer for 2025 in shares of restricted stock in lieu of cash, the Company awarded him additional shares of restricted stock, equal to 60% of the value of the deferred Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $16.64. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

For 2025, the reporting person elected to take 100% of her Board retainer in the form of shares of restricted stock with a three-year restriction period. Because the reporting person elected to take her Board retainer for 2025 in shares of restricted stock in lieu of cash, the Company awarded her additional shares of restricted stock, equal to 60% of the value of the Board retainer. The price of the securities acquired by the reporting person with respect to the Board retainer is based upon the ten (10) day average stock price of the common stock, which is equal to $16.64. The number of securities issued is equal to the total value of the Board retainer plus the value of the additional shares divided by such 10-day average stock price.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.18 to $16.33. The reporting person undertakes to provide Community Healthcare Trust Incorporated, any security holder of Community Healthcare Trust Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) of this Form 4.

On April 30, 2025, the reporting person inadvertently purchased shares of common stock during a closed window period. On the same date, the transaction was reversed at a slight loss by having the shares sold on the open market.

On April 30, 2025, the reporting person inadvertently purchased shares of common stock during a closed window period. On the same date, the transaction was reversed at a slight loss by having the shares sold on the open market.

For 2025, the reporting person agreed to take 50% of his salary in shares of restricted stock with a five-year restriction period. Because the reporting person elected to take 50% of his base salary for 2025 in shares of restricted stock with a five-year restriction period, the Company awarded Mr. Dupuy additional compensation, in restricted stock, equal to 25% of his annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2025, which was $19.03.

For 2025, the reporting person agreed to take 50% of his salary in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take 50% of his base salary for 2025 in shares of restricted stock with an eight-year restriction period, the Company awarded Mr. Monroe additional compensation, in restricted stock, equal to 50% of his annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2025, which was $19.03.

For 2025, the reporting person agreed to take 50% of his salary in shares of restricted stock with an eight-year restriction period. Because the reporting person elected to take 50% of his base salary for 2025 in shares of restricted stock with an eight-year restriction period, the Company awarded Mr. Meyer additional compensation, in restricted stock, equal to 50% of his annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2025, which was $19.03.

For 2025, the reporting person agreed to take 50% of her salary in shares of restricted stock with a three-year restriction period. Because the reporting person elected to take 50% of her base salary for 2025 in shares of restricted stock with a three-year restriction period, the Company awarded Ms. Stach additional compensation, in restricted stock, equal to 15% of her annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2025, which was $19.03.